The Burroughs Wellcome Fund aims to stimulate growth of new connections between thinkers working in largely disconnected fields who might together change the course of climate change’s impact on human health. In the three years between Fall 2023 and Summer 2026, we will dedicate $1M to supporting small, early stage grants of $2,500–$50,000 toward achieving this goal.
We are particularly but not exclusively interested in activities that build connections between basic/early biomedical scientific approaches and ecological, environmental, geological, geographic, and planetary-scale thinking, as well as with population-focused fields including epidemiology and public health, demography, economics, and urban planning. Also of interest is work piloting new approaches or new interactions toward reducing the impact of health-centered activities, for example, developing more sustainable systems for health care, care delivery, and biomedical research systems. Another area of interest is preparation for the impacts of extreme weather and other crises that can drive large scale disruptions that will immediately impact human health and delivery of health care. Public outreach, climate communication, and education efforts focused on the intersection of climate and health are also appropriate for this call.
Work focused on issues like heat, particulates, fire, and f looding is not competitive if it does not pull in substantial thinking about climate. Simply stating that heat, for example, is increasingly viewed as a problem is not enough.
This program supports work conceived through many kinds of creative thinking. Successful applicants include not only academic scientists, physicians, and public health experts, but also community organizations, science outreach centers, non-biomedical academic departments, and more. A list of grant recipients from earlier rounds is available on the program’s web page.
Proposals will be reviewed quarterly from September 2021 through July 2026. After each quarterly review, we will support or decline applications.
BWF funds people, not just projects.
Winning profiles show:
self-directed independence
demonstrated creativity
track record of initiative
original intellectual contributions (not extension of PI’s program)
Letters must strongly emphasize leadership potential.
BWF celebrates hybrid scientists:
physics/CS → biology
engineering → medicine
quantitative → immunology
computational + experimental fluency
Monoculture CVs rarely stand out.
Committees respond to:
new paradigms
non-incremental questions
reframing of field assumptions
Being merely technically clever is insufficient.
Patterns among winners:
first/second-author papers in high-impact journals OR
computational/tool papers with broad adoption
unusually innovative work, even if N < 3 papers
Trajectory matters more than sheer volume.
Winning dossiers demonstrate:
divergently framed hypotheses
distinct research niches
original conceptual architecture
Dependency on mentor’s program → risk flag.
BWF tolerates conceptual risk only if:
technical fail-safes are present
alternative readouts prepared
endpoint feasibility shown
No contingency = panel anxiety.
BWF favors scientists who:
build platforms
form communities
democratize methods
translate concepts across silos
They’re investing in future leaders.
Winning applications consistently:
articulate structured mentorship committees
describe milestone-based guidance
demonstrate institutional support (protected time)
Weak departmental signals reduce confidence.
Panelists repeatedly emphasize:
clarity of scientific “why”
storytelling that frames the problem, not just technique
boldness grounded in logic
Dry proposals underperform.
Applicants who highlight:
what only they can uniquely do
their niche in the ecosystem
score disproportionately well.
Successful threads:
computational tool development
single-cell analysis frameworks
generative modeling of biological systems
causal network inference
synthetic biology design algorithms
Engineering/quantitative novelty matters.
Patterns:
host–pathogen interaction mechanisms
immune evasion logic
cell-state transitions
pathogen-driven signaling perturbations
Pure descriptive pathogenomics underperforms.
Strong signals:
direct patient relevance
bridging clinical and mechanistic work
unmet medical needs
longitudinal sample access
Clinic-based feasibility is scrutinized.
Funded proposals often:
quantify off-target risk
build predictive toxicity models
develop ML-based safety algorithms
improve regulatory trial design
Policy/analytics hybrids excel.
✅ Ability to articulate a 5–10 year trajectory
Where is the field going, and how will you shape it?
✅ Societal relevance (without mission drift)
Ethical, equitable, scalable impact matters.
✅ Demonstrated teaching, mentoring, outreach
“Community builder” signals predict success.
✘ Incremental extension of mentor’s science
✘ Too descriptive — weak mechanistic hypothesis
✘ Excessive technical ambition without fallback
✘ Unclear independence trajectory
✘ Vague institutional support
✘ Narrow skillset (no cross-disciplinary element)
✘ No narrative arc linking projects to identity
The applicant is the product.
Conceptual creativity outweighs technical virtuosity.
Leadership potential > publication count.
Interdisciplinarity is not optional.
Funded individuals often show:
one “signature” paper/tool
original pipeline or assay
public resource contribution
conference presence outside home domain
evidence of thought leadership (reviews, workshops)
Aim 1 — Foundational mechanistic question
Aim 2 — Causal perturbation to test generality
Aim 3 — Computational or technological platform extension
(with contingency fallback)
Two deep aims > three superficial ones.
Boards like budgets that:
invest in innovation infrastructure
modestly support personnel
avoid large equipment asks
include computational cost clarity
Consumes aligned with risk mitigation are viewed favorably.
Avoid emphasizing:
incremental improvement
exploratory correlation
feasibility unknown
descriptive profiling
Replace with:
causal testing
model-driven interrogation
generalizable frameworks
A competitive BWF candidate:
✅ cross-disciplinary thinker
✅ independently conceptualized research niche
✅ bold, causal questions
✅ fallback strategies for high-risk tasks
✅ strong mentorship ecosystem
✅ trajectory toward scientific leadership
✅ platform or tool projected impact
✅ community-building ethos
Applications must be submitted by non-profit organizations or degree-granting institutions in the United States or Canada. Applicant organizations may submit multiple proposals, but an individual may only serve as a principal investigator/project director on one application during each review period.
This call focuses on developing partnerships. Proposals from single institutions must develop partnerships that do not already occur naturally: for example, institutions proposing to link work already connected by other grants will not be competitive. Proposals from more than one institution are responsive. Academic institutions, professional societies, and advocacy organizations are only a few of the appropriate drivers of proposals. Only non-profit institutions may be supported by BWF’s award, but non-profits may involve for profit organizations in their proposals. This program does not support biomedical research projects proposed by individual investigators, but only by collaborative teams.
Eligible proposals will include rationale/vision for the project, including who it is intended to impact.
Individuals may only serve twice as directors (principal investigators/project directors) for proposals supported over time by this program. Current and past awardees from other BWF programs are eligible to apply.
Sponsor Institute/Organizations: Burroughs Wellcome Fund
Sponsor Type: Corporate/Non-Profit
Address: 21 T.W. Alexander Drive Durham, NC 27713-2847 919-991-5100
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
Jan 22, 2026
Jan 22, 2026
$2,500
up to 50000
Affiliation: Burroughs Wellcome Fund
Address: 21 T.W. Alexander Drive Durham, NC 27713-2847 919-991-5100
Website URL: https://www.bwfund.org/wp-content/uploads/2021/09/BWF_CCHH_RFP_2025_v3.pdf
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.